Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease

BACKGROUND: Improved outcomes and the availability of clinical trials of hematopoietic cell transplantation (HCT) from alternate donors and genetically modified autologous hematopoietic progenitor cells have expanded the applicability of HCT for sickle cell disease (SCD). To understand the perspecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Cynthia B., Bakshi, Nitya, Ross, Diana, Loewenstein, George, Krishnamurti, Lakshmanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246626/
https://www.ncbi.nlm.nih.gov/pubmed/33034129
http://dx.doi.org/10.1002/pbc.28749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246626/
https://www.ncbi.nlm.nih.gov/pubmed/33034129
http://dx.doi.org/10.1002/pbc.28749

Ejemplares similares